Publication | Open Access

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

Placebo-controlled InductionGastroenterologyPathologyClinical GastroenterologyGastrointestinal PathologyMaintenance StudiesUlcerative ColitisMedicineActive Ulcerative Colitis